Cancer overdiagnosis: A challenge in the era of screening

Dunn, 2017 Srivastava, 2019, Cancer overdiagnosis: a biological challenge and clinical dilemma, Nat Rev Cancer, 19, 349, 10.1038/s41568-019-0142-8 Woloshin, 2021, Overdiagnosis: it's official, BMJ, 375, n2854, 10.1136/bmj.n2854 Moynihan, 2012, Preventing overdiagnosis: how to stop harming the healthy, BMJ, 344, e3502, 10.1136/bmj.e3502 Klotz, 2012, Cancer overdiagnosis and overtreatment, Curr Opin Urol, 22, 203, 10.1097/MOU.0b013e32835259aa Hofmann, 2021, Overdiagnosis: one concept, three perspectives, and a model, Eur J Epidemiol, 36, 361, 10.1007/s10654-020-00706-4 Coon, 2014, Overdiagnosis: how our compulsion for diagnosis may be harming children, Pediatrics, 134, 1013, 10.1542/peds.2014-1778 Kramer, 2009, Cancer screening: the clash of science and intuition, Annu Rev Med, 60, 125, 10.1146/annurev.med.60.101107.134802 Brawley, 2021, Overdiagnosis in the age of digital cancer screening, J Natl Cancer Inst, 113, 1, 10.1093/jnci/djaa081 Mukherjee, 2010 Welch, 2010, Overdiagnosis in cancer, J Natl Cancer Inst., 102, 605, 10.1093/jnci/djq099 Draisma, 2003, Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer, J Natl Cancer Inst, 95, 868, 10.1093/jnci/95.12.868 Croswell, 2010, Principles of cancer screening: lessons from history and study design issues, Semin Oncol, 37, 202, 10.1053/j.seminoncol.2010.05.006 Sandhu, 2012, Overdiagnosis of prostate cancer, J Natl Cancer Inst Monogr, 2012, 146, 10.1093/jncimonographs/lgs031 Callister, 2021, Overdiagnosis in lung cancer screening, Lancet Respir Med, 9, 7, 10.1016/S2213-2600(20)30553-1 Brodersen, 2020, Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials, Breathe, 16, 10.1183/20734735.0013-2020 Welch, 2019, Epidemiologic signatures in cancer, N Engl J Med, 381, 1378, 10.1056/NEJMsr1905447 Sohaib, 2014, Incidental lesion in oncology patients: kidneys, Cancer Imaging, 14, 044, 10.1186/1470-7330-14-S1-O44 Pinsky, 2017, Incidental renal tumours on low-dose CT lung cancer screening exams, J Med Screen, 24, 104, 10.1177/0969141316657115 O'Sullivan, 2018, Prevalence and outcomes of incidental imaging findings: umbrella review, BMJ, 361, k2387, 10.1136/bmj.k2387 Ganguli, 2019, Cascades of care after incidental findings in a US National Survey of Physicians, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.13325 Loomans-Kropp, 2020, Thyroid incidentalomas in association with low-dose computed tomography in the National Lung Screening Trial, Am J Epidemiol, 189, 27, 10.1093/aje/kwz219 Hock, 2002, Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data, J Urol, 167, 57, 10.1016/S0022-5347(05)65382-7 Mitchell, 2000, Incidental detection of preclinical renal tumors with electron beam computed tomography: report of 26 consecutive operated patients, J Comput Assist Tomogr, 24, 843, 10.1097/00004728-200011000-00003 Hara, 2000, Incidental extracolonic findings at CT colonography, Radiology, 215, 353, 10.1148/radiology.215.2.r00ap33353 Saad, 2019, Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study, Clin Genitourin Cancer, 17, 46, 10.1016/j.clgc.2018.10.002 Welch, 2019, Stumbling onto cancer: avoiding Overdiagnosis of renal cell carcinoma, Am Fam Physician, 99, 145 Maris, 2010, Recent advances in neuroblastoma, N Engl J Med, 362, 2202, 10.1056/NEJMra0804577 Ajiki, 1998, Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control., 9, 631, 10.1023/A:1008897123707 Woods, 2002, Screening of infants and mortality due to neuroblastoma, N Engl J Med, 346, 1041, 10.1056/NEJMoa012387 Schilling, 2002, Neuroblastoma screening at one year of age, N Engl J Med, 346, 1047, 10.1056/NEJMoa012277 Berthold, 2021, Neuroblastoma screening at 1 year of age: the final results of a controlled trial, JNCI Cancer Spectr, 5, 10.1093/jncics/pkab041 Katanoda, 2009, Secular trends in neuroblastoma mortality before and after the cessation of national mass screening in Japan, J Epidemiol, 19, 266, 10.2188/jea.JE20090037 Shinagawa, 2017, The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: a descriptive study, Int J Cancer, 140, 618, 10.1002/ijc.30482 Pacini, 2012, Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 23, 119 Xu, 2021, The overdiagnosis of thyroid micropapillary carcinoma: the rising incidence, inert biological behavior, and countermeasures, J Oncol, 2021, 10.1155/2021/5544232 Vaccarella, 2016, Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis, N Engl J Med, 375, 614, 10.1056/NEJMp1604412 Davies, 2006, Increasing incidence of thyroid cancer in the United States, 1973-2002, JAMA, 295, 2164, 10.1001/jama.295.18.2164 Roman, 2017, The thyroid cancer epidemic, 2017 perspective, Curr Opin Endocrinol Diabetes Obes, 24, 332, 10.1097/MED.0000000000000359 Hakala, 2012, Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients, Scand J Surg, 101, 301, 10.1177/145749691210100415 Welch, 2018, Saving thyroids - overtreatment of small papillary cancers, N Engl J Med, 379, 310, 10.1056/NEJMp1804426 James, 2019, Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years, Surgery, 166, 41, 10.1016/j.surg.2019.01.007 Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702 Pettus, 2008, Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy, Eur Urol, 53, 370, 10.1016/j.eururo.2007.07.031 Bell, 2015, Prevalence of incidental prostate cancer: a systematic review of autopsy studies, Int J Cancer, 137, 1749, 10.1002/ijc.29538 Kimura, 2021, Global trends of latent prostate cancer in autopsy studies, Cancers, 13, 359, 10.3390/cancers13020359 Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696 Andriole, 2012, Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up, J Natl Cancer Inst, 104, 125, 10.1093/jnci/djr500 Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084 Schroder, 2012, Prostate-cancer mortality at 11 years of follow-up, N Engl J Med, 366, 981, 10.1056/NEJMoa1113135 Moyer, 2012, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 120, 10.7326/0003-4819-157-2-201207170-00459 Force, 2018, Screening for prostate cancer: US preventive services task force recommendation statement, JAMA, 319, 1901, 10.1001/jama.2018.3710 Marcus, 2006, Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis, J Natl Cancer Inst, 98, 748, 10.1093/jnci/djj207 Hocking, 2010, Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, J Natl Cancer Inst, 102, 722, 10.1093/jnci/djq126 Oken, 2011, Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, JAMA, 306, 1865, 10.1001/jama.2011.1591 Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Patz, 2014, Overdiagnosis in low-dose computed tomography screening for lung cancer, JAMA Intern Med, 174, 269, 10.1001/jamainternmed.2013.12738 2019, Lung cancer incidence and mortality with extended follow-up in the national lung screening trial, J Thorac Oncol, 14, 1732, 10.1016/j.jtho.2019.05.044 Dammas, 2001, Identification of small lung nodules at autopsy: implications for lung cancer screening and overdiagnosis bias, Lung Cancer, 33, 11, 10.1016/S0169-5002(01)00190-8 Gao, 2022, Association of computed tomographic screening promotion with lung cancer overdiagnosis among Asian women, JAMA Intern Med, 182, 283, 10.1001/jamainternmed.2021.7769 Bleyer, 2012, Effect of three decades of screening mammography on breast-cancer incidence, N Engl J Med, 367, 1998, 10.1056/NEJMoa1206809 Welch, 2016, Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness, N Engl J Med, 375, 1438, 10.1056/NEJMoa1600249 Nelson, 2009, Screening for breast cancer: an update for the U.S. Preventive Services Task Force, Ann Intern Med, 151, 727, 10.7326/0003-4819-151-10-200911170-00009 Kalager, 2012, Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program, Ann Intern Med, 156, 491, 10.7326/0003-4819-156-7-201204030-00005 Chaltiel, 2021, Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?, BMJ Open, 11, 10.1136/bmjopen-2020-046353 Nelson, 2016, Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive services task force recommendation, Ann Intern Med, 164, 256, 10.7326/M15-0970 Ryser, 2022, Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort, Ann Intern Med, 175, 471, 10.7326/M21-3577 Welch, 2021, The rapid rise in cutaneous melanoma diagnoses, N Engl J Med, 384, 72, 10.1056/NEJMsb2019760 Lee, 2021, The future of precision prevention for advanced melanoma, Front Med, 8 Wolff, 2009, Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med, 150, 194, 10.7326/0003-4819-150-3-200902030-00009 Weinstock, 2017, Skin biopsy utilization and melanoma incidence among Medicare beneficiaries, Br J Dermatol, 176, 949, 10.1111/bjd.15077 Weyers, 2012, The 'epidemic' of melanoma between under- and overdiagnosis, J Cutan Pathol, 39, 9, 10.1111/j.1600-0560.2011.01831.x Rousi, 2022, Increased incidence of melanoma in children and adolescents in Finland in 1990-2014: nationwide re-evaluation of histopathological characteristics, Ann Med, 54, 244, 10.1080/07853890.2022.2026001 Koh, 1991, Cutaneous melanoma, N Engl J Med, 325, 171, 10.1056/NEJM199107183250306 Glusac, 2012, The melanoma 'epidemic': lessons from prostate cancer, J Cutan Pathol, 39, 17, 10.1111/j.1600-0560.2011.01848.x Welch, 2005, Skin biopsy rates and incidence of melanoma: population based ecological study, BMJ, 331, 481, 10.1136/bmj.38516.649537.E0 Herbert, 2020, Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data, Melanoma Res, 30, 279, 10.1097/CMR.0000000000000489 Glasziou, 2020, Estimating the magnitude of cancer overdiagnosis in Australia, Med J Aust, 213, 189, 10.5694/mja2.50578 Watts, 2021, Association between melanoma detected during routine skin checks and mortality, JAMA Dermatol, 157, 1425, 10.1001/jamadermatol.2021.3884 Cantor, 2007, Introduction: cancer control and prevention in the twentieth century, Bull Hist Med, 81, 1, 10.1353/bhm.2007.0001 Schwartz, 2004, Enthusiasm for cancer screening in the United States, JAMA, 291, 71, 10.1001/jama.291.1.71 Dunn, 2013, The word "cancer": how language can corrupt thought, BMJ, 347, f5328, 10.1136/bmj.f5328 Woloshin, 2012, Cancer screening campaigns–getting past uninformative persuasion, N Engl J Med, 367, 1677, 10.1056/NEJMp1209407 Ransohoff, 2002, Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback, Am J Med, 113, 663, 10.1016/S0002-9343(02)01235-4 Schwartz, 2000, US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey, West J Med, 173, 307, 10.1136/ewjm.173.5.307 Yu, 2017, Women's awareness and perceived importance of the harms and benefits of mammography screening: results from a 2016 national survey, JAMA Intern Med, 177, 1381, 10.1001/jamainternmed.2017.2247 Nickel, 2020, Media coverage of calls to rename low-risk cancers: a content analysis, BMJ Open, 10, 10.1136/bmjopen-2020-038087 O'Keeffe, 2021, Journalists' views on media coverage of medical tests and overdiagnosis: a qualitative study, BMJ Open, 11, 10.1136/bmjopen-2020-043991 Copp, 2022, Interventions to improve media coverage of medical research: a codesigned feasibility and acceptability study with Australian journalists, BMJ Open, 12, 10.1136/bmjopen-2022-062706 Esserman, 2013, Overdiagnosis and overtreatment in cancer: an opportunity for improvement, JAMA, 310, 797, 10.1001/jama.2013.108415 Veronesi, 2009, Breast cancer classification: time for a change, J Clin Oncol, 27, 2427, 10.1200/JCO.2008.21.2647 Ganz, 2010, Quality-of-life issues in patients with ductal carcinoma in situ, J Natl Cancer Inst Monogr, 2010, 218, 10.1093/jncimonographs/lgq029 NIH State-of-the-Science Conference: Diagnosis and Management of Ductal Carcinoma in Situ (DCIS), September 22-24. (Accessed August 21,2013) 2009 [Available from: http://consensus.nih.gov/2009/dcis.htm. Nickel, 2018, Renaming low risk conditions labelled as cancer, BMJ, 362, k3322, 10.1136/bmj.k3322 Semsarian, 2022, Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?, Br J Dermatol, 186, 1030, 10.1111/bjd.21010 Ma, 2021, Rethinking low-risk papillary thyroid cancers <1cm (Papillary Microcarcinomas): an evidence review for recalibrating diagnostic thresholds and/or alternative labels, Thyroid., 31, 1626, 10.1089/thy.2021.0274 Smith-Bindman, 2003, Comparison of screening mammography in the United States and the United kingdom, JAMA, 290, 2129, 10.1001/jama.290.16.2129 Pickles, 2022, Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study, BMJ Open, 12, 10.1136/bmjopen-2022-061211 Crispo, 2013, Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series, BMC Cancer, 13, 15, 10.1186/1471-2407-13-15 Domingo, 2013, Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers, Eur J Cancer Prev, 22, 21, 10.1097/CEJ.0b013e328354d324 Kornberg, 2019, Genomic prostate score, PI-RADS version 2 and progression in men with prostate cancer on active surveillance, J Urol, 201, 300, 10.1016/j.juro.2018.08.047 Paik, 2004, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med, 351, 2817, 10.1056/NEJMoa041588 Esserman, 2017, The WISDOM Study: breaking the deadlock in the breast cancer screening debate, NPJ Breast Cancer, 3, 34, 10.1038/s41523-017-0035-5 Welch, 2022, The crazy confluence of Congress, liquid biopsies, Medicare, and health inequities, STAT